Kelly Michele Malloy, MD, MBA, FACS
Manage Your Profile
About
Kelly Michele Malloy MD, MBA, FACS is a head and neck surgical oncologist at the University of Michigan where she is professor of otolaryngology- head and neck surgery and Chief Clinical Officer for the adult hospitals of Michigan Medicine Health. Dr. Malloy's clinical work focuses on the comprehensive surgical management of patients with head and neck malignancies, with additional expertise in head and neck melanoma and complex microvascular free tissue reconstruction. Her primary research interest is in surgical education, specifically in applications of simulation in otolaryngology; she is the immediate past chair of the Simulation Education Committee of the American Academy of Otolaryngology- Head and Neck Surgery. Dr. Malloy is the program director of the head and neck surgical oncology and microvascular reconstruction fellowship at Michigan; she is committed to the daily work of training the next generation of comprehensive head and neck surgeons and increasing the diversity of our field to better serve our patients. She also serves as the associate chief clinical officer for adult surgical and rehabilitation services at Michigan Medicine Health, overseeing 10 surgical and rehabilitation inpatient care units and a 32 room operating theater suite. A passionate advocate for gender and racial equity and inclusion, she has served as the inaugural co-chair for the American Head and Neck Society's Margaret F. Butler Outstanding Mentor of Women in Head and Neck Surgery Award. Most recently she was elected Finance Officer of the Women In Otolaryngology (WIO) Section and chairs the WIO Endowment Committee.
Qualifications
-
MBAUniversity of Michigan, Ann Arbor, MI, United States
2022 - 2025
Research Overview
Surgical simulation education, quality and performance improvement in otolaryngology and multidisciplinary inpatient surgical care.
Recent Publications
-
Tikhtman R, Hasan D, Gao R, Buchakjian M, Casper K, Chinn S, Forner D, Malloy K, Prince M, Stucken C, Yalamanchi P, Heft Neal M. 2025 Oct 13;Proceeding / Abstract / PosterPostoperative shoulder dysfunction following latissimus dorsi versus pectoralis major flap reconstruction
-
Regan SN, Shah J, Suresh K, Morales KA, Cao Y, Aryal M, Rosen BS, Walline H, Lee C, Aldous J, Swiecicki PL, Casper KA, Chinn SB, Malloy KM, Prince MEP, Stucken CL, Shuman AG, Heft-Neal M, Lyden TH, Blakely A, Ambrose M, Chad Brenner J, Worden FP, Mierzwa ML. Advances in Radiation Oncology, 2025 Oct 1; 10 (10):Journal ArticleProspective Phase II Trial of Definitive Chemoradiation and Concurrent Nivolumab in Locally Advanced p16+ Oropharynx Cancer
DOI:10.1016/j.adro.2025.101832 -
Smith JD, Gensterblum-Miller E, Forner DWA, Yalamanchi P, Buchakjian MR, Chinn SB, Shuman AG, Casper KA, Malloy KM, Stucken CL, Mclean SA, Mierzwa ML, Shah J, Swiecicki PL, Worden FP, Prince MEP, Spector ME, Brenner JC, Heft Neal ME. Otolaryngology Head and Neck Surgery United States, 2025 Sep 1; 173 (3): 645 - 650.Journal ArticleTumor Hypoxia and CD8+ T-Cell Infiltration in Patients With Advanced Laryngeal Cancer
DOI:10.1002/ohn.1291 PMID: 40323140 -
Regan SN, Shah J, Suresh K, Morales KA, Cao Y, Aryal M, Rosen BS, Walline H, Lee C, Aldous J, Swiecicki PL, Casper KA, Chinn SB, Malloy KM, Prince MEP, Stucken CL, Shuman AG, Heft-Neal M, Lyden TH, Blakely A, Ambrose M, Brenner JC, Worden FP, Mierzwa M. Advances in Radiation Oncology, 2025 Aug 15; 101832 - 101832.Journal ArticleProspective Phase II Trial of Definitive Chemoradiation and Concurrent Nivolumab in Locally Advanced p16+ Oropharynx Cancer
DOI:10.1016/j.adro.2025.101832 -
2025 Mar 4;PresentationHead & Neck Microvascular Reconstruction Workshop for Residents and Fellows
-
Edwards DM, Gharzai LA, Wang W, Mayo C, Suresh K, Schipper M, Evans JR, Malloy K, Chinn SB, Prince M, Spector M, Shuman A, Stucken C, Swiecicki PL, Worden F, Jarema J, Henderson C, Kovach A, Brenner C, Shah JL, Mierzwa ML, Casper K. Head and Neck, 2024 Nov 1; 46 (11): 2687 - 2698.Journal ArticleFollow-up for human papillomavirus-related oropharynx cancer concentrated on unequal symptom change (FOCUS): Prospective patient-reported outcome collection
DOI:10.1002/hed.27778 PMID: 38680087 -
Regan SN, Aryal MP, Suresh K, Rosen BS, Walline H, Prince ME, Malloy K, Casper K, Shuman A, Chinn SB, Heft-Neal ME, Swiecicki PL, Worden F, Shah JL, Cao Y, Brenner C, Mierzwa ML. International Journal of Radiation Oncology • Biology • Physics, 2024 Oct 1; 120 (2): s131 - s131.Proceeding / Abstract / PosterImaging Metrics and HPV ctDNA Kinetics in a Phase II Immuno-Chemoradiation Trial for Locoregionally Advanced p16+ Oropharynx Cancer
DOI:10.1016/j.ijrobp.2024.07.238 -
Prince ADP, Heft Neal ME, Buchakjian MR, Chinn SB, Stucken CL, Casper KA, Malloy KM, Prince MEP, Rosko AJ, McHugh JB, Spector ME. Otolaryngology Head and Neck Surgery United States, 2024 Sep 1; 171 (3): 785 - 790.Journal ArticlePharyngeal Mucosal Margin Vessel Counts Predict Pharyngocutaneous Fistula in Salvage Laryngectomy
DOI:10.1002/ohn.865 PMID: 38881401